| MeSH term | MeSH ID | Detail |
|---|---|---|
| Pancreatic Neoplasms | D010190 | 77 associated lipids |
| Arteriosclerosis | D001161 | 86 associated lipids |
| Body Weight | D001835 | 333 associated lipids |
Total
3
Norethindrone
Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.
Cross Reference
Introduction
To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with Norethindrone?
Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with Norethindrone
PubChem Associated disorders and diseases
What pathways are associated with Norethindrone
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with Norethindrone?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with Norethindrone?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with Norethindrone?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with Norethindrone?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with Norethindrone?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with Norethindrone
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| MENDEL EB and HABERMAN S | COMPARISON OF SEROLOGICAL, FROG, AND HORMONE WITHDRAWAL BLEEDING TESTS FOR EARLY PREGNANCY. | 1964 | Am. J. Obstet. Gynecol. | pmid:14241509 |
| Beyer G and Behrman SJ | Myometrial activity and the IUCD. 3. Effect of contraceptive pills. | 1970 | Am. J. Obstet. Gynecol. | pmid:5410390 |
| McLean FW et al. | Relationship between the oral contraceptive and folic acid metabolism. Serum folate concentrations. | 1969 | Am. J. Obstet. Gynecol. | pmid:4892225 |
| Engmann L et al. | Progestogen therapy during pituitary desensitization with gonadotropin-releasing hormone agonist prevents functional ovarian cyst formation: a prospective, randomized study. | 1999 | Am. J. Obstet. Gynecol. | pmid:10486466 |
| Diddle AW et al. | Oral contraceptive medication: a prolonged experience. | 1966 | Am. J. Obstet. Gynecol. | pmid:5939017 |
| Levin JH et al. | Comparison of norethindrone and medroxyprogesterone acetate with natural progesterone and estradiol in stimulating prolactin production from cultured endometrial stromal cells. | 1990 | Am. J. Obstet. Gynecol. | pmid:2147816 |
| Rowan JP | "Estrophasic" dosing: A new concept in oral contraceptive therapy. | 1999 | Am. J. Obstet. Gynecol. | pmid:9988834 |
| Dören M et al. | Resistance of pelvic arteries and plasma lipids in postmenopausal women: comparative study of tibolone and continuous combined estradiol and norethindrone acetate replacement therapy. | 2000 | Am. J. Obstet. Gynecol. | pmid:10992176 |
| Chihal HJ et al. | Estrogen potency of oral contraceptive pills. | 1975 | Am. J. Obstet. Gynecol. | pmid:1115120 |
| Reisman H et al. | A multicenter randomized comparison of cycle control and laboratory findings with oral contraceptive agents containing 100 microg levonorgestrel with 20 microg ethinyl estradiol or triphasic norethindrone with ethinyl estradiol. | 1999 | Am. J. Obstet. Gynecol. | pmid:10561675 |
| Brakman P et al. | Effects of different systemic contraceptives on blood fibrinolysis. | 1970 | Am. J. Obstet. Gynecol. | pmid:5410044 |
| Caillouette JC and Koehler AL | Phasic contraceptive pills and functional ovarian cysts. | 1987 | Am. J. Obstet. Gynecol. | pmid:3296761 |
| Beck LR et al. | New long-acting injectable microcapsule contraceptive system. | 1979 | Am. J. Obstet. Gynecol. | pmid:114054 |
| Rabinovici J et al. | Acute abdominal condition caused by retrograde bleeding in a postmenopausal patient on estrogen-progestogen therapy. | 1985 | Am. J. Obstet. Gynecol. | pmid:4061537 |
| McQuarrie HG et al. | Cytogenetic studies on women using oral contraceptives and their progeny. | 1970 | Am. J. Obstet. Gynecol. | pmid:4096928 |
| Pochi PE and Strauss JS | Lack of androgen effect on human sebaceous glands with low-dosage norethindrone. | 1965 | Am. J. Obstet. Gynecol. | pmid:5843402 |
| Gossain VV et al. | Effect of oral contraceptives on plasma glucose, insulin, and glucagon levels. | 1983 | Am. J. Obstet. Gynecol. | pmid:6356926 |
| Andersen RN et al. | Response of the binding capacity of plasma testosterone-estradiol-binding globulin to norethindrone, 2 mg., and mestranol, 0.1 mg., in polycystic ovarian disease. | 1976 | Am. J. Obstet. Gynecol. | pmid:944533 |
| Di Paola G et al. | Oral contraceptives and carbohydrate metabolism. | 1968 | Am. J. Obstet. Gynecol. | pmid:4172445 |
| Givens JR et al. | The effectiveness of two oral contraceptives in suppressing plasma androstenedione, testosterone, LH, and FSH, and in stimulating plasma testosterone-binding capacity in hirsute women. | 1976 | Am. J. Obstet. Gynecol. | pmid:1251854 |
| Price TM et al. | Single- and multiple-dose pharmacokinetics of a low-dose oral contraceptive in women with chronic renal failure undergoing peritoneal dialysis. | 1993 | Am. J. Obstet. Gynecol. | pmid:8498419 |
| Sørensen MB et al. | Temporal changes in cardiac function and cerebral blood flow during sequential postmenopausal hormone replacement. | 2001 | Am. J. Obstet. Gynecol. | pmid:11174477 |
| Darney PD | Hormonal implants: contraception for a new century. | 1994 | Am. J. Obstet. Gynecol. | pmid:8178903 |
| Martin PL et al. | Graded sequential therapy in the menopause: a double-blind study. | 1971 | Am. J. Obstet. Gynecol. | pmid:4938602 |
| Dodek OI and Kotz HL | Syndrome of anovulation following the oral contraceptives. | 1967 | Am. J. Obstet. Gynecol. | pmid:4951888 |
| O'Neill RT | Pregnancy following hormonal therapy for adenocarcinoma of the endometrium. | 1970 | Am. J. Obstet. Gynecol. | pmid:4952585 |
| Dören M et al. | Superior compliance and efficacy of continuous combined oral estrogen-progestogen replacement therapy in postmenopausal women. | 1995 | Am. J. Obstet. Gynecol. | pmid:7503183 |
| Vanin CM et al. | Lumbar vertebral density and mechanical properties in aged ovariectomized rats treated with estrogen and norethindrone or norgestimate. | 1995 | Am. J. Obstet. Gynecol. | pmid:7503190 |
| Moawad AH and Bengtsson LP | In vivo studies of the motility pattern of the nonpregnant human uterus. 3. The effect of anovulatory pills. | 1968 | Am. J. Obstet. Gynecol. | pmid:5690296 |
| Roy S et al. | Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring. | 1980 | Am. J. Obstet. Gynecol. | pmid:6767404 |
| Goldzieher JW et al. | Nervousness and depression attributed to oral contraceptives: a double-blind, placebo-controlled study. | 1971 | Am. J. Obstet. Gynecol. | pmid:4108553 |
| Maqueo M et al. | Morphology of the cervix in women treated with synthetic progestins. | 1966 | Am. J. Obstet. Gynecol. | pmid:4162849 |
| Kjos SL et al. | Effect of low-dose oral contraceptives on carbohydrate and lipid metabolism in women with recent gestational diabetes: results of a controlled, randomized, prospective study. | 1990 | Am. J. Obstet. Gynecol. | pmid:2256489 |
| Hammerstein J | Prodrugs: advantage or disadvantage? | 1990 | Am. J. Obstet. Gynecol. | pmid:2256526 |
| Dooley RR et al. | Polypoid cervicitis in cystic fibrosis patients receiving oral contraceptives. | 1974 | Am. J. Obstet. Gynecol. | pmid:4818428 |
| McShane PM et al. | Thrombotic thrombocytopenic purpura associated with oral contraceptives: a case report. | 1983 | Am. J. Obstet. Gynecol. | pmid:6681940 |
| Williams SR et al. | A study of combined continuous ethinyl estradiol and norethindrone acetate for postmenopausal hormone replacement. | 1990 | Am. J. Obstet. Gynecol. | pmid:2309827 |
| Check JH et al. | Pregnancy in premature ovarian failure after therapy with oral contraceptives despite resistance to previous human menopausal gonadotropin therapy. | 1989 | Am. J. Obstet. Gynecol. | pmid:2492146 |
| Portman DJ et al. | A randomized, double-blind, placebo-controlled, multicenter study that assessed the endometrial effects of norethindrone acetate plus ethinyl estradiol versus ethinyl estradiol alone. | 2003 | Am. J. Obstet. Gynecol. | pmid:12592236 |
| Saleh WA et al. | A randomized trial of three oral contraceptives: comparison of bleeding patterns by contraceptive types and steroid levels. | 1993 | Am. J. Obstet. Gynecol. | pmid:8317516 |
| Riis BJ et al. | Norethisterone acetate in combination with estrogen: effects on the skeleton and other organs. A review. | 2002 | Am. J. Obstet. Gynecol. | pmid:12389012 |
| Vorherr H | Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management. | 1986 | Am. J. Obstet. Gynecol. | pmid:3511705 |
| Bergink W et al. | Serum pharmacokinetics of orally administered desogestrel and binding of contraceptive progestogens to sex hormone-binding globulin. | 1990 | Am. J. Obstet. Gynecol. | pmid:2147817 |
| Djerassi C | Chemical birth of the pill. 1992. | 2006 | Am. J. Obstet. Gynecol. | pmid:16389046 |
| Crook D et al. | Oral contraceptives and coronary heart disease: modulation of glucose tolerance and plasma lipid risk factors by progestins. | 1988 | Am. J. Obstet. Gynecol. | pmid:3287933 |
| Pritchard JA and Pritchard SA | Blood pressure response to estrogen-progestin oral contraceptive after pregnancy-induced hypertension. | 1977 | Am. J. Obstet. Gynecol. | pmid:607805 |
| Damber MG et al. | A quantitative study of the pregnancy zone protein in sera of woman taking oral contraceptives. | 1976 | Am. J. Obstet. Gynecol. | pmid:55075 |
| Chang MC | Development of the oral contraceptives. | 1978 | Am. J. Obstet. Gynecol. | pmid:356615 |
| Spellacy WN et al. | Prospective study of carbohydrate metabolism in women using a triphasic oral contraceptive containing norethindrone and ethinyl estradiol for 3 months. | 1988 | Am. J. Obstet. Gynecol. | pmid:3052079 |
| GOODRICH SM and WOOD JE | PERIPHERAL VENOUS DISTENSIBILITY AND VELOCITY OF VENOUS BLOOD FLOW DURING PREGNANCY OR DURING ORAL CONTRACEPTIVE THERAPY. | 1964 | Am. J. Obstet. Gynecol. | pmid:14233661 |